Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors
Lei Jin, Tao Yan, Linzhi Zhang, Bowen Chen, Jiamin Cheng, Xiaoqiang Gao, Zherui Liu, Yinyin Li, Shi Zuo, Yinying Lu
Topics & Concepts
Hepatocellular carcinomaMedicineHepatologyVirologyColorectal surgeryHepatitis B virusTyrosine kinaseVirusHepatitis C virusTyrosine-kinase inhibitorInternal medicineCancer researchCancerAbdominal surgeryReceptorHepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus StudiesCancer Immunotherapy and Biomarkers